AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update A Guideline From the American Heart Association and…

Overview of attention for article published in JACC, November 2011

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog
policy: 4 policy sources

twitter: 2 X users
guideline: 7 clinical guideline sources

Readers on

mendeley: 409 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 63,422 followers.

@cardiobrief I am shocked about the beta blocker rec. The AHA/ACC guidelines recommend up to 3 years post-MI http://t.co/8PEJIeCUED

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic... http://t.co/vicyIiAg

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.

Login to access the Sentiment Analysis related to this output.